|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.02 EUR | +3.22% |
|
+5.30% | -0.71% |
| Jan. 29 | Modest Recovery for Medincell Following Sharp Decline |  |
| Jan. 28 | Medincell S.A. Reports Sales Results for the Fourth Quarter and Full 2025 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | €35.26 | +40.94% | 8 | |||||
| Average | 35.26 | +40.94% | 8 | ||||||
| Weighted average by Cap. | 35.26 | +40.94% | 8 |
- Stock Market
- Equities
- MEDCL Stock
- Sector MedinCell S.A.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
